Lilly’s $400 Billion Surge Reshapes Big Pharma, Rally
Eli Lilly has added roughly $400 billion in market value over the past year, fueling a dramatic shift in Big Pharma a...
Discover which credit card offers the best rewards points to enhance your spending. Make informed choices for optimal rewards.
27,333 articlesEli Lilly has added roughly $400 billion in market value over the past year, fueling a dramatic shift in Big Pharma a...
Rivian’s quality metrics, limited service footprint, and steep pricing are prompting investor caution in 2026. This r...
Jim Cramer defies the pullback, urging investors to buy DoorDash despite a roughly 30% year-to-date drop. The call hi...
Schwab Fundamental International Equity ETF (FNDF) packs around 900 holdings into a single fund and has posted impres...
Dell Technologies shares have surged about 120% in a blistering run, pushing the stock toward record levels as AI inf...
Eli Lilly stock fell about 5% as investors awaited the FDA's April decision on orforglipron. Novo Nordisk's intensifi...
SanDisk has surged to record highs, up 700% YTD, with AI-driven demand and supply constraints propelling the run. The...
Bitcoin is pulling back from its peak, a move many investors fear. History, though, suggests cycles, patience, and di...
After a dramatic fall, Canopy Growth has staged a cautious comeback. This article breaks down whether canopy growth s...
Oracle’s stock has fallen from its AI-redemption peak as management bets heavily on data-center compute. Analysts are...
One staffing stock plunged 56% in the last year, but a large new stake worth almost $10 million could signal a forthc...
The Fundrise VCX fund, once a magnet for IPO-obsessed investors, dropped 45% from its peak as market enthusiasm for p...